Kite Realty's 52% stake in Legacy West highlights real estate trends with strong Q1 growth. Click here to read an analysis of ...

Kite Pharma has struck deals with China’s Fosun Pharma and Japan’s Daiichi Sankyo to develop and market its T-cell cancer immunotherapy technology in Asia. California-based Kite is one of ...

Kite Pharma’s share price has dived after it emerged that a patient has died from cerebral oedema while being treated with its CAR-T therapy, KTE-C19. Investors were spooked by the news ...

Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...

In the early-stage financings of Cougar Biotech (acquired by J&J), Kite Pharma (acquired by Gilead), Velcera (acquired by Perrigo) and Ziopharm Oncology, Tim played a significant role. He has ...

In the early-stage financings of Cougar Biotech (acquired by J&J), Kite Pharma (acquired by Gilead), Velcera (acquired by Perrigo) and Ziopharm Oncology, Tim played a significant role. He has ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Questex's Fierce Pharma today announces the call for submissions for the 2025 Fierce Pharma Marketing Awards, which honors the most compelling, influential ...

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centers Financing ...

"We are excited to enter the next phase of Ousia Pharma's journey, advancing our groundbreaking platform towards clinical development," said Anders B. Klein, PhD, CEO of Ousia Pharma. "The strong ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...